- Report
- November 2025
- 145 Pages
Global
From €3508EUR$3,950USD£3,066GBP
- Report
- October 2025
- 150 Pages
Global
From €2531EUR$2,850USD£2,212GBP
€3419EUR$3,850USD£2,988GBP
- Report
- July 2025
- 150 Pages
Global
From €3419EUR$3,850USD£2,988GBP
€4307EUR$4,850USD£3,764GBP
- Report
- July 2025
- 350 Pages
Global
From €4395EUR$4,949USD£3,841GBP
- Report
- June 2025
- 400 Pages
Global
From €4395EUR$4,949USD£3,841GBP
- Report
- January 2025
- 250 Pages
Global
From €4440EUR$4,999USD£3,880GBP
- Report
- June 2025
- 150 Pages
Global
From €2397EUR$2,699USD£2,095GBP
- Report
- June 2025
- 150 Pages
Global
From €2397EUR$2,699USD£2,095GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Report
- June 2025
- 150 Pages
Global
From €2397EUR$2,699USD£2,095GBP
- Report
- June 2025
- 150 Pages
Global
From €2397EUR$2,699USD£2,095GBP
- Report
- May 2025
- 300 Pages
Global
From €4395EUR$4,949USD£3,841GBP
- Report
- June 2025
- 138 Pages
Global
From €3508EUR$3,950USD£3,066GBP
- Report
- December 2024
- 144 Pages
Global
From €3508EUR$3,950USD£3,066GBP
- Report
- January 2025
- 140 Pages
Global
From €3508EUR$3,950USD£3,066GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more